drugset / Trial / NCT00672984

Guanfacine Immediate-release Electrocardiogram Results (QTc) Study

NCT00672984

Phase 1 Completed 83 enrolled Shire
RandomizedCrossoverQuadruple-blindBasic science

Summary

To assess the effect of immediate-release guanfacine hydrochloride, administered at therapeutic and supratherapeutic doses, on QT/QTc in healthy normal males and females

Timeline

Start
2008-04-18
Primary completion
2008-08-07
Completion
2008-08-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Guanfacine Small molecule 4 mg
Subject Guanfacine Small molecule 8 mg
Comparator Moxifloxacin Small molecule 400 mg

Indications

No indication recorded.